UNSPSC 51372702: Metethoheptazine

This classification denotes an opioid receptor agonist with the molecular formula C17H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S36J5ZY2TH, chemically known as 1,3-dimethyl-4-carbethoxy-4-phenylhexamethylenimin but generally known as metethoheptazine, which bears US NIH Compound Identifier 176888. European Medicines Agency schedules Metethoheptazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08829MIG. The term METETHOHEPTAZINE is an International Non-Proprietary Name.

UNSPSC 51372702 Metethoheptazine is a Commodity code that nominally describes a specific pharmaceutical compound, but recent state and local procurement activity shows minimal or no genuine demand for metethoheptazine itself. The single solicitation tagged to this code — Seminole County, Florida's IFB 60459723LAS — actually seeks naloxone and drug deactivation systems, products unrelated to metethoheptazine. The mismatch suggests either a data-entry error in the jurisdiction's coding system or that metethoheptazine has no active state and local procurement market. State and local governments are not currently buying metethoheptazine under this code.

No representative recent opportunities exist for metethoheptazine procurement at the state and local level. The single available record is a Seminole County, Florida IFB posted June 30, 2026, with a response deadline of July 26, 2023 (a date inconsistency within the source itself), but it addresses naloxone and drug deactivation systems only, with no connection to the code's stated commodity. Geographic and issuing-body analysis is not applicable to this code, as the taxonomy does not reflect genuine market demand.